Meetings & Events

Meeting Goals/Objectives:

• Determine preliminary SBIRT study results - if any, and results of completed studies
• Discuss barriers to study completion, and ways barriers have been overcome
• Discuss study successes/accomplishments and ways to implement these successes into ongoing studies
• Importance: provide evidence base for policy changes, some of which are now occurring

Topics Discussed:

• Presentations:
  • 15 grantees, 3 of these PI's of completed studies
  • Results, barriers and successes presented
  • SAMHSA and WHO-ASSIST and plans
• Group discussions:
  • Scientific questions that remain to be addressed (assuming efficacy) for SBIRT dissemination/implementation?
  • Products or dissemination work that would help facilitate the implementation process?
  • Need to validate Computer Based Interventions and short screeners
  • Role of US in world-wide dissemination, resources

Take Home Messages and Conclusions:

• Conclusions:
  • No results from active studies, but large number, prior with youth/CBI show efficacy
  • Determining mechanism of action of SBIRT important
  • Technology for fidelity issues, training and implementation
  • Select one drug to study
  • Efficacy must be shown
• Future Research:
  • Best indirect/proxy measures for outcomes
  • Mechanism of action of SBIRT
  • Bundled or Individual SBIRT programs most effective/practical, OBSSR initiative
  • Studies with Youth and injured youth, vulnerable populations, pregnant
  • SBIRT studies in different settings
  • MJ and health consequences
  • Studies re: optimal dissemination/implementation
  • What is the level of evidence needed for world-wide implementation of SBIRT as universal intervention